杜皮鲁玛
美波利祖马布
奥马佐单抗
医学
哮喘
皮肤病科
内科学
免疫学
免疫球蛋白E
抗体
嗜酸性粒细胞
作者
Katrine Prætorius,Daniel Pilsgaard Henriksen,Johannes Schmid,Pernille Printzlau,Lars Pedersen,Hanne Madsen,Ehm A. Andersson,Louise Klokker,Bo Chawes
出处
期刊:ERJ Open Research
[European Respiratory Society]
日期:2021-06-17
卷期号:7 (3): 00306-2021
被引量:5
标识
DOI:10.1183/23120541.00306-2021
摘要
This indirect comparison of dupilumab, mepolizumab and omalizumab for patients with severe type 2 asthma fulfilling start-up criteria for more than one drug shows no significant efficacy differenceshttps://bit.ly/3pK9Nf9
科研通智能强力驱动
Strongly Powered by AbleSci AI